Press Releases

Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary development technology platforms – S-DUAL™ and DEVELOPICK™ – at this year's BioProcess International Conference and Exhibition in Boston. S-DUAL™ is a high-yield bispecific antibody platform...

Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing accelerator, announced an update on the development of Oxilio’s OXL001 product. Oxilio is pleased to announce...

Velocity Clinical Research (“Velocity”), the leading integrated research site organization with 40 locations across 19 U.S. states and Europe, announces the findings of its U.S. patient survey, which aimed  to better understand patient preference for study decentralization activities in...

Quanticate, a global data-focused clinical research organisation (CRO), has partnered with leading cancer research organisation, Cancer Research UK, to launch the DETERMINE study which will test a range of therapies specifically targeting key genetic changes in cancer cells. The first...

Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy. “Glioblastoma is one...

Connect in Pharma — the new annual event from Easyfairs — had its debut launch on 14 & 15 September in Geneva. Key players from companies in the pharmaceutical industry, including Bayer, Merck, Pfizer, Roche, Johnson & Johnson and...

Abzena, a leading CDMO providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a significant upgrade to its research and development capabilities in Cambridge. This includes an investment in B cell discovery technologies...